Horizons: Perspectives on Psychedelics conference recap

Podcasts

Podcast
MIN LISTEN

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison give a report on their recent trip to the Horizons: Perspectives on Psychedelics conference in New York. They discuss the following topics:

(1:40) Horizons: Perspectives on Psychedelics
(1:52) MeetDelic conference 
(6:00) The diverse ways in which psychedelic medicine is being research and brought to the people
(8:33) MAPS Public Benefit Corporation
(10:42) Proposed REMS for MDMA-assisted psychotherapy for PTSD
(16:33) Oregon Psilocybin Services Act ballot measure 109
(18:19) The challenges of combing ancient practices with modern medicine and giving credit where credit is due and cultural appropriation
(21:40) Enthea non-profit dedicated to proving insurance coverage for psychedelic therapies
(23:19) North Star
(29:10) Laying the groundwork for the delivery of psychedelic medicine once it's FDA approved
(33:14) Gul Dolen's research on "Critical periods" for learning and change opened up by psychedelics
(38:13) Matt Johnson's research grant
(38:55) How to Do the Work, by Nicole LePera
(40:10) Be cautious about making big changes immediately following a psychedelic experience
(42:33) Psychedelics, mindfulness, and contemplative practices episode
(44:20) TiHKAL and PiHKAL
(46:13) Hamilton Morris and 5MEO-DMT
(49:55) Usona Research Institute

Email us questions and feedback at psychfrontiers@novamind.ca
Learn more about our podcast at https://www.psychedelictherapyfrontiers.com/
Learn more about Novamind at https://www.novamind.ca/

Disclaimer: The content of this podcast does not constitute medical advice or mental health treatment. Consult with a medical/mental health professional if you believe you are in need of mental health treatment.


Would you like to be a guest
on our podcast?

Enter your info and we'll reach out to you asap.

Podcast

Would you like to be a guest on our podcast?

By signing up you consent to the Privacy Policy & Terms of Use.
Questions?
Call us toll-free 1-833-NUMINUS (686-4687)
crosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram